Table 1 Characteristics of the participants from the three cohorts
ART PWH GW/UNCa | ART PWH SVb | ECc SV | |
|---|---|---|---|
N | 46 | 4 | 3 |
Median age (years)(IQR) | 36 (30–42) | 40 (32–46) | 52 (51–54) |
Sex (self-reported) | |||
Male (%) | 42 (91.3) | 4 (100) | 2 (66.6) |
Female (%) | 4 (8.7) | - | 1 (33.3) |
Race (self-reported) (%) | |||
African-American | 20 (43.5) | ||
Non-Hispanic, White | 19 (41.3) | ||
Hispanic, White | 3 (6.5) | 4 (100%) | 3 (100) |
Asian | 2 (4.3) | ||
Other/unknown | 2 (4.3) | ||
Median time since diagnosis (months)(IQR) | 89 (41–156) | 92 (81–103) | 310 (290–343) |
Median CD4 nadir (cells/mm3)(IQR) | 420 (324–531) | 499 (423–594) | 433 (313–523) |
Stage at time of ART initiation (%) | |||
Acute (%) | 11 (23.9) | ||
Chronic (%) | 35 (76.1) | 4 (100) | |
Median time on ART (months)(IQR) | 72 (37–113) | 60 (47–85) | |
Median time suppressed (<50 copies/ml)(months)(IQR) | 44 (27–91) | 56 (38–80) | |
Median CD4 count (cells/mm3)(IQR) | 719 (615–851) | 1103 (984–1143) | 758 (552–782) |
